Evidence map›Paper›PMID 39180673›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2025

Hypericin-loaded in modified theranostic liposome nanoplatform: a preliminary in vivo study of targeting and diagnosis.

Flávia Amanda Pedroso de Morais, Rodolfo Bento Balbinot, Amanda Beatriz Kawano Bakoshi, Danielle Lararin-Bidoia, Katieli da Silva Souza Campanholi, Ranulfo Combuca da Silva, Bruna Martins de França, Renato Sonchini Gonçalves, Tânia Ueda-Nakamura, Sueli de Oliveira Silva and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Flávia Amanda Pedroso de MoraisTechnological Innovation Laboratory in Pharmaceuticals and Cosmetics Development, State University of Maringá, Maringá, PR, 87020-900, Brazil. flaviaapmorais@hotmail.com.
Rodolfo Bento BalbinotTechnological Innovation Laboratory in Pharmaceuticals and Cosmetics Development, State University of Maringá, Maringá, PR, 87020-900, Brazil.
Amanda Beatriz Kawano BakoshiTechnological Innovation Laboratory in Pharmaceuticals and Cosmetics Development, State University of Maringá, Maringá, PR, 87020-900, Brazil.
Danielle Lararin-BidoiaTechnological Innovation Laboratory in Pharmaceuticals and Cosmetics Development, State University of Maringá, Maringá, PR, 87020-900, Brazil.
Katieli da Silva Souza CampanholiDepartment of Chemistry, State University of Maringá, Maringá, PR, 87020-900, Brazil.
Ranulfo Combuca da SilvaDepartment of Chemistry, State University of Maringá, Maringá, PR, 87020-900, Brazil.
Bruna Martins de FrançaDepartment of Chemistry, Federal University of Rio de Janeiro, 149 Athos da Silveira Ramos Ave., Rio de Janeiro, RJ, 21941-909, Brazil.
Renato Sonchini GonçalvesLaboratory of Chemistry of Natural Products, Department of Chemistry, Center of Exact Sciences and Technology, Federal University of Maranhão, São Luís, MA, 65080-805, Brazil.
Tânia Ueda-NakamuraTechnological Innovation Laboratory in Pharmaceuticals and Cosmetics Development, State University of Maringá, Maringá, PR, 87020-900, Brazil.
Sueli de Oliveira SilvaTechnological Innovation Laboratory in Pharmaceuticals and Cosmetics Development, State University of Maringá, Maringá, PR, 87020-900, Brazil.
Wilker CaetanoDepartment of Chemistry, State University of Maringá, Maringá, PR, 87020-900, Brazil.
Celso Vataru NakamuraTechnological Innovation Laboratory in Pharmaceuticals and Cosmetics Development, State University of Maringá, Maringá, PR, 87020-900, Brazil.

Funding

National Council for Scientific, Technological Development CNPq-162876/2020-3 process
6 · The paper itself

Abstract

Modified theranostic liposomes were created by combining phospholipid 1,2-dipalmitoyl-sn-3-glycerol-phosphatidylcholine with two previously modified Pluronic

Indexed as

PerylenePhotosensitizing AgentsTheranostic NanomedicineAnimalsAnthracenesCell Line, TumorFemaleHumansLiposomesMaleMiceNanoparticlesNeoplasmsPhotochemotherapyTissue DistributionAnthraceneshypericinLiposomesPerylenePhotosensitizing AgentsCoated liposomesDPPC lipidF127 Pluronic®FolateSpermine

Identifiers

PMID39180673

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.